Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Summit Technology (BEAM) -- Ignore unavailable to you. Want to Upgrade?

To: Manny Gugliuzza who wrote (675)	1/30/1998 8:28:00 AM
From: pappy	Read Replies (1) \| Respond to of 1386

Considering all the BS going on with VISX withholding royalty fees of almost $1 million per month from PP and Beam's net revenues increasing from $17.8 Million to $21.5 Million, I would have to say, "yes". However, whether the market will accept this is unknown to me. In addition, VISX laser sales are decreasing and as far as VISX revenues, I question how VISX is accounting for them, since it states it's not reporting the extra revenue from the LASIK procedures in their earnings. Yet in their press releases, they talk about how they wont be able to meet analyst's earnings expectations if they were to continue contributing these royalties to PP. However, then their earnings come out exceeding analyst's expectations. Go figure...creative accounting?...or a bunch of crap...Pappy